SAN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sanofi SA

Watchlist Manager

Watchlist

Price: 76.03 EUR -0.43% Market Closed

Market Cap: €92.3B

	Sanofi SA PAR:SAN	FR
	Transgene SA OTC:TRGNF	FR
M	McCormick & Company Inc F:MCX	US
M	McCormick & Company Inc SWB:MCX	US
A	ALLETE Inc F:AEBA	US
Z	Zhejiang Expressway Co Ltd XMUN:ZHJ	CN
	TYMLEZ Group Ltd ASX:TYM	AU
	Redwire Corp NYSE:RDW	US
	Bird Construction Inc TSX:BDT	CA
T	Tempur Sealy International Inc NYSE:SGI	US
	Life360 Inc ASX:360	US
	Anika Therapeutics Inc NASDAQ:ANIK	US
	Philex Mining Corp F:0PX	PH
P	Primerica Inc F:PI7	US
P	PICC Property and Casualty Co Ltd F:PJC	CN
A	Aptargroup Inc F:AGT	US
T	Tupperware Brands Corp XMUN:TUP	US

Profitability Summary

Sanofi SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

72%

Strong 3Y Average Gross Margin

71%

Gross Margin is Increasing

70% > 72%

Healthy Operating Margin

21%

Sustainable 3Y Average Operating Margin

21%

Declining Operating Margin

26% > 21%

Healthy Net Margin

16%

Sustainable 3Y Average Net Margin

16%

Declining Net Margin

19% > 16%

Exceptional Free Cash Flow Margin

18%

Strong 3Y Average Free Cash Flow Margin

16%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.